Bell Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.5M Sell
2,719
-315
-10% -$319K 0.74% 55
2025
Q4
$3.28M Sell
3,034
-4,072
-57% -$3.89M 0.88% 52
2025
Q3
$5.42M Sell
7,106
-4,248
-37% -$3.16M 1.48% 17
2025
Q2
$8.85M Buy
11,354
+877
+8% +$681K 1.95% 9
2025
Q1
$8.65M Buy
10,477
+4,840
+86% +$4.03M 1.59% 17
2024
Q4
$4.35M Buy
+5,637
New +$4.67M 0.79% 58

Other funds holding LLY

Bell Asset Management's LLY Position: Q1 2026 in Review

Bell Asset Management reduced its Eli Lilly (LLY) stake by 10% in Q1 2026, selling an estimated $319K and leaving 2,719 shares worth $2.5M. The position accounts for 0.74% of the portfolio, ranked #55.

Bell Asset Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.85M in Q2 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bell Asset Management held 2,719 shares of Eli Lilly worth $2.5M as of Q1 2026.
  • Bell Asset Management sold 315 Eli Lilly shares in Q1 2026, an estimated $319K.
  • Eli Lilly made up 0.74% of Bell Asset Management's portfolio in Q1 2026, its #55 holding.
  • Bell Asset Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Bell Asset Management's Eli Lilly position peaked at $8.85M in Q2 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bell Asset Management's 13F filing for Q1 2026, filed 29 Apr 2026.